Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Gene Therapy|October 16, 2025
Spleen tyrosine kinase (SYK) inhibition suppresses growth of gastrointestinal neuroendocrine tumor cells: a pilot study in two cell linesAngeliki Ditsiou, Lara Toffoli, Viviana Vella, et al.
Open Biology|September 28, 2021
The multifaceted role of lemur tyrosine kinase 3 in health and diseaseAngeliki Ditsiou, Teresa Gagliano, Mark Samuels, et al.
Endocrine Oncology (Bristol, England)|August 20, 2025
FAK inhibition disrupts tumor growth, apoptosis, and transcriptional regulation in GI-NETsLara Toffoli, Angeliki Ditsiou, Luca Triboli, et al.
Human Molecular Genetics|February 17, 2018
Predominant patterns of splicing evolution on human, chimpanzee and macaque evolutionary lineagesJieyi Xiong, Xi Jiang, Angeliki Ditsiou, et al.
Cellular Signalling|August 7, 2021
hMOB2 deficiency impairs homologous recombination-mediated DNA repair and sensitises cancer cells to PARP inhibitorsRamazan Gundogdu, M Kadir Erdogan, Angeliki Ditsiou, et al.
Endocrine Connections|April 30, 2019
EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?Giulia Bresciani, Angeliki Ditsiou, Chiara Cilibrasi, et al.
International Journal of Molecular Sciences|January 8, 2023
The Inhibitory Properties of a Novel, Selective LMTK3 Kinase InhibitorAlessandro Agnarelli, Andrea Lauer Betrán, Athanasios Papakyriakou, et al.
Oncogene|March 16, 2018
LMTK3 confers chemo-resistance in breast cancerJustin Stebbing, Kalpit Shah, Lei Cheng Lit, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 14, 2024
Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in GlioblastomaViviana Vella, Angeliki Ditsiou, Anna Chalari, et al.
The Journal of Clinical Investigation|March 4, 2020
PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progressionTeresa Gagliano, Kalpit Shah, Sofia Gargani, et al.
Pageof 2